3PAT
 
 | | COMPARISON BETWEEN THE CRYSTAL AND THE SOLUTION STRUCTURES OF THE EF HAND PARVALBUMIN | | Descriptor: | CALCIUM ION, PARVALBUMIN | | Authors: | Padilla, A, Cave, A, Parello, J, Etienne, G, Baldellon, C. | | Deposit date: | 1994-03-22 | | Release date: | 1994-07-31 | | Last modified: | 2022-03-16 | | Method: | SOLUTION NMR | | Cite: | Comparison between the Crystal and the Solution Structures of the EF Hand Parvalbumin
To be Published
|
|
2PAS
 | | COMPARISON BETWEEN THE CRYSTAL AND THE SOLUTION STRUCTURES OF THE EF HAND PARVALBUMIN | | Descriptor: | CALCIUM ION, PARVALBUMIN | | Authors: | Padilla, A, Cave, A, Parello, J, Etienne, G, Baldellon, C. | | Deposit date: | 1994-03-22 | | Release date: | 1994-06-22 | | Last modified: | 2022-03-16 | | Method: | SOLUTION NMR | | Cite: | Comparison between the Crystal and the Solution Structures of the EF Hand Parvalbumin
To be Published
|
|
6QPK
 | |
4P5E
 | | CRYSTAL STRUCTURE OF HUMAN DNPH1 (RCL) WITH 6-NAPHTHYL-PURINE-RIBOSIDE-MONOPHOSPHATE | | Descriptor: | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1, 6-(naphthalen-2-yl)-9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purine, CALCIUM ION | | Authors: | Padilla, A, Labesse, G, Kaminski, P.A. | | Deposit date: | 2014-03-16 | | Release date: | 2014-08-20 | | Last modified: | 2023-12-20 | | Method: | X-RAY DIFFRACTION (1.35 Å) | | Cite: | 6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: Synthesis, structural studies and cytotoxic activities.
Eur.J.Med.Chem., 85C, 2014
|
|
4P5D
 | | CRYSTAL STRUCTURE OF RAT DNPH1 (RCL) WITH 6-NAPHTHYL-PURINE-RIBOSIDE-MONOPHOSPHATE | | Descriptor: | 2'-deoxynucleoside 5'-phosphate N-hydrolase 1, 6-(naphthalen-2-yl)-9-(5-O-phosphono-beta-D-ribofuranosyl)-9H-purine, SULFATE ION | | Authors: | Padilla, A, Labesse, G, Kaminski, P.A. | | Deposit date: | 2014-03-16 | | Release date: | 2014-08-20 | | Last modified: | 2023-12-20 | | Method: | X-RAY DIFFRACTION (2.11 Å) | | Cite: | 6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: Synthesis, structural studies and cytotoxic activities.
Eur.J.Med.Chem., 85C, 2014
|
|
2MMM
 | |
5JHJ
 | | M. Oryzae effector AVR-Pia mutant H3 | | Descriptor: | Antivirulence protein AVR-Pia | | Authors: | Padilla, A, deGuillen, K. | | Deposit date: | 2016-04-21 | | Release date: | 2017-03-29 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Recognition of the Magnaporthe oryzae Effector AVR-Pia by the Decoy Domain of the Rice NLR Immune Receptor RGA5.
Plant Cell, 29, 2017
|
|
4KXM
 | |
4KXL
 | |
4KXN
 | |
2KLH
 | | NMR Structure of RCL in complex with GMP | | Descriptor: | GUANOSINE-5'-MONOPHOSPHATE, c-Myc-responsive protein Rcl | | Authors: | Padilla, A, Yang, Y, Labesse, G, Zhang, C, Kaminski, P.A. | | Deposit date: | 2009-07-02 | | Release date: | 2009-10-20 | | Last modified: | 2021-11-10 | | Method: | SOLUTION NMR | | Cite: | Structural characterization of the mammalian deoxynucleotide N-hydrolase Rcl and its stabilizing interactions with two inhibitors
J.Mol.Biol., 394, 2009
|
|
4FYH
 | | Crystal structure of rcl with phospho-triciribine | | Descriptor: | 5-methyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine, Deoxyribonucleoside 5'-monophosphate N-glycosidase, SULFATE ION | | Authors: | Labesse, G, Padilla, A, Kaminski, P.A. | | Deposit date: | 2012-07-04 | | Release date: | 2013-01-02 | | Last modified: | 2024-02-28 | | Method: | X-RAY DIFFRACTION (2.44 Å) | | Cite: | Structure of the oncoprotein Rcl bound to three nucleotide analogues.
Acta Crystallogr.,Sect.D, 69, 2013
|
|
4FYK
 | | Crystal structure of rcl with 5'-phiosphorothioate-adenosine | | Descriptor: | ADENOSINE -5'-THIO-MONOPHOSPHATE, Deoxyribonucleoside 5'-monophosphate N-glycosidase, SULFATE ION | | Authors: | Labesse, G, Padilla, A, Kaminski, P.A. | | Deposit date: | 2012-07-04 | | Release date: | 2013-01-02 | | Last modified: | 2024-02-28 | | Method: | X-RAY DIFFRACTION (1.79 Å) | | Cite: | Structure of the oncoprotein Rcl bound to three nucleotide analogues.
Acta Crystallogr.,Sect.D, 69, 2013
|
|
4FYI
 | | Crystal structure of rcl with 6-cyclopentyl-AMP | | Descriptor: | Deoxyribonucleoside 5'-monophosphate N-glycosidase, N-cyclopentyladenosine 5'-(dihydrogen phosphate) | | Authors: | Labesse, G, Padilla, A, Kaminski, P.A. | | Deposit date: | 2012-07-04 | | Release date: | 2013-01-02 | | Last modified: | 2024-02-28 | | Method: | X-RAY DIFFRACTION (1.96 Å) | | Cite: | Structure of the oncoprotein Rcl bound to three nucleotide analogues.
Acta Crystallogr.,Sect.D, 69, 2013
|
|
1G33
 | | CRYSTAL STRUCTURE OF RAT PARVALBUMIN WITHOUT THE N-TERMINAL DOMAIN | | Descriptor: | CALCIUM ION, PARVALBUMIN ALPHA, SULFATE ION | | Authors: | Thepaut, M, Strub, M.P, Cave, A, Baneres, J.L, Berchtold, M.W, Dumas, C, Padilla, A. | | Deposit date: | 2000-10-23 | | Release date: | 2001-10-03 | | Last modified: | 2023-08-09 | | Method: | X-RAY DIFFRACTION (1.44 Å) | | Cite: | Structure of rat parvalbumin with deleted AB domain: implications for the evolution of EF hand calcium-binding proteins and possible physiological relevance.
Proteins, 45, 2001
|
|
1JSG
 | | CRYSTAL STRUCTURE OF P14TCL1, AN ONCOGENE PRODUCT INVOLVED IN T-CELL PROLYMPHOCYTIC LEUKEMIA, REVEALS A NOVEL B-BARREL TOPOLOGY | | Descriptor: | ONCOGENE PRODUCT P14TCL1 | | Authors: | Hoh, F, Yang, Y.-S, Guignard, L, Padilla, A, Stern, R.-H, Lhoste, J.-M, Van Tilbeurgh, H. | | Deposit date: | 1997-12-03 | | Release date: | 1998-03-18 | | Last modified: | 2024-02-07 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Crystal structure of p14TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology.
Structure, 6, 1998
|
|
8ACX
 | |
6SGO
 | | NMR structure of MLP124017 | | Descriptor: | Secreted protein | | Authors: | Barthe, P, de Guillen, K, Padilla, A, Hecker, A. | | Deposit date: | 2019-08-05 | | Release date: | 2019-12-18 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Structural genomics applied to the rust fungus Melampsora larici-populina reveals two candidate effector proteins adopting cystine knot and NTF2-like protein folds.
Sci Rep, 9, 2019
|
|
8C8A
 | | The NMR structure of the MAX28 effector from Magnaporthe oryzae | | Descriptor: | But2 domain-containing protein | | Authors: | Lahfa, M, Padilla, A, de Guillen, K, Kroj, T, Roumestand, C, Barthe, P. | | Deposit date: | 2023-01-19 | | Release date: | 2024-02-14 | | Method: | SOLUTION NMR | | Cite: | 1H, 15N Backbone and side-chain NMR assignments for a MAX effector from Magnaporthe oryzae
To Be Published
|
|
3F45
 | | Structure of the R75A mutant of rat alpha-Parvalbumin | | Descriptor: | CALCIUM ION, Parvalbumin alpha, SULFATE ION | | Authors: | Hoh, F, Padilla, A. | | Deposit date: | 2008-10-31 | | Release date: | 2009-07-07 | | Last modified: | 2023-11-01 | | Method: | X-RAY DIFFRACTION (2 Å) | | Cite: | Removing the invariant salt bridge of parvalbumin increases flexibility in the AB-loop structure
Acta Crystallogr.,Sect.D, 65, 2009
|
|
7ZK0
 | | The NMR structure of the MAX60 effector from Magnaporthe Oryzae | | Descriptor: | MAX effector protein | | Authors: | Lahfa, M, Padilla, A, de Guillen, K, Pissarra, J, Raji, M, Cesari, S, Kroj, T, Gladieux, P, Roumestand, C, Barthe, P. | | Deposit date: | 2022-04-12 | | Release date: | 2023-04-26 | | Last modified: | 2023-11-08 | | Method: | SOLUTION NMR | | Cite: | 1 H, 13 C, 15 N backbone and side-chain NMR assignments for three MAX effectors from Magnaporthe oryzae.
Biomol.Nmr Assign., 16, 2022
|
|
7ZKD
 | | The NMR structure of the MAX47 effector from Magnaporthe Oryzae | | Descriptor: | MAX effector protein | | Authors: | Lahfa, M, Padilla, A, de Guillen, K, Pissarra, J, Raji, M, Cesari, S, Kroj, T, Gladieux, P, Roumestand, C, Barthe, P. | | Deposit date: | 2022-04-12 | | Release date: | 2023-04-26 | | Last modified: | 2023-11-08 | | Method: | SOLUTION NMR | | Cite: | 1 H, 13 C, 15 N backbone and side-chain NMR assignments for three MAX effectors from Magnaporthe oryzae.
Biomol.Nmr Assign., 16, 2022
|
|
7ZJY
 | | The NMR structure of the MAX67 effector from Magnaporthe Oryzae | | Descriptor: | MAX effector protein | | Authors: | Lahfa, M, Padilla, A, de Guillen, K, Pissarra, J, Raji, M, Cesari, S, Kroj, T, Gladieux, P, Roumestand, C, Barthe, P. | | Deposit date: | 2022-04-12 | | Release date: | 2023-04-26 | | Last modified: | 2023-11-08 | | Method: | SOLUTION NMR | | Cite: | 1 H, 13 C, 15 N backbone and side-chain NMR assignments for three MAX effectors from Magnaporthe oryzae.
Biomol.Nmr Assign., 16, 2022
|
|
1QTT
 | | SOLUTION STRUCTURE OF THE ONCOPROTEIN P13MTCP1 | | Descriptor: | PRODUCT OF THE MTCP1 ONCOGENE | | Authors: | Guignard, L, Padilla, A, Mispelter, J, Yang, Y.-S, Stern, M.-H, Lhoste, J.-M, Roumestand, C. | | Deposit date: | 1999-06-29 | | Release date: | 2001-01-19 | | Last modified: | 2018-01-24 | | Method: | SOLUTION NMR | | Cite: | Backbone dynamics and solution structure refinement of the 15N-labeled human oncogenic protein p13MTCP1: comparison with X-ray data.
J.Biomol.NMR, 17, 2000
|
|
1QTU
 | | SOLUTION STRUCTURE OF THE ONCOPROTEIN P13MTCP1 | | Descriptor: | PROTEIN (PRODUCT OF THE MTCP1 ONCOGENE) | | Authors: | Guignard, L, Padilla, A, Mispelter, J, Yang, Y.-S, Stern, M.-H, Lhoste, J.-M, Roumestand, C. | | Deposit date: | 1999-06-29 | | Release date: | 2001-01-19 | | Last modified: | 2018-01-24 | | Method: | SOLUTION NMR | | Cite: | Backbone dynamics and solution structure refinement of the 15N-labeled human oncogenic protein p13MTCP1: comparison with X-ray data.
J.Biomol.NMR, 17, 2000
|
|
